These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Whole-genome microarray detects deletions and loss of heterozygosity of chromosome 3 occurring exclusively in metastasizing uveal melanoma. Lake SL; Coupland SE; Taktak AF; Damato BE Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):4884-91. PubMed ID: 20445121 [TBL] [Abstract][Full Text] [Related]
30. Histopathologic, immunohistochemical, ultrastructural, and cytogenetic analysis of oncocytic uveal melanoma. Verdijk RM; van den Bosch T; Naus NC; Paridaens D; Mooy CM; de Klein A Arch Ophthalmol; 2011 Nov; 129(11):1501-2. PubMed ID: 22084225 [No Abstract] [Full Text] [Related]
31. Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma. Maat W; Ly LV; Jordanova ES; de Wolff-Rouendaal D; Schalij-Delfos NE; Jager MJ Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):505-10. PubMed ID: 18234992 [TBL] [Abstract][Full Text] [Related]
32. Multiplex fluorescence in situ hybridization identifies novel rearrangements of chromosomes 6, 15, and 18 in primary uveal melanoma. Sisley K; Tattersall N; Dyson M; Smith K; Mudhar HS; Rennie IG Exp Eye Res; 2006 Sep; 83(3):554-9. PubMed ID: 16684523 [TBL] [Abstract][Full Text] [Related]
33. Fine needle aspiration biopsy in uveal melanoma. Char DH; Miller TR; Ljung BM; Howes EL; Stoloff A Acta Cytol; 1989; 33(5):599-605. PubMed ID: 2781961 [TBL] [Abstract][Full Text] [Related]
34. Molecular cytogenetic analysis of archival uveal melanoma with known clinical outcome. Mensink HW; Kiliç E; Vaarwater J; Douben H; Paridaens D; de Klein A Cancer Genet Cytogenet; 2008 Mar; 181(2):108-11. PubMed ID: 18295662 [TBL] [Abstract][Full Text] [Related]
35. Increased p21-activated kinase-1 expression is associated with invasive potential in uveal melanoma. Pavey S; Zuidervaart W; van Nieuwpoort F; Packer L; Jager M; Gruis N; Hayward N Melanoma Res; 2006 Aug; 16(4):285-96. PubMed ID: 16845324 [TBL] [Abstract][Full Text] [Related]
36. Cytogenetics of uveal melanoma: a 7-year clinical experience. Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643 [TBL] [Abstract][Full Text] [Related]
37. Prediction of prognosis in patients with uveal melanoma using fluorescence in situ hybridisation. Patel KA; Edmondson ND; Talbot F; Parsons MA; Rennie IG; Sisley K Br J Ophthalmol; 2001 Dec; 85(12):1440-4. PubMed ID: 11734517 [TBL] [Abstract][Full Text] [Related]
38. Characterization of complex chromosomal abnormalities in uveal melanoma by fluorescence in situ hybridization, spectral karyotyping, and comparative genomic hybridization. Naus NC; van Drunen E; de Klein A; Luyten GP; Paridaens DA; Alers JC; Ksander BR; Beverloo HB; Slater RM Genes Chromosomes Cancer; 2001 Mar; 30(3):267-73. PubMed ID: 11170284 [TBL] [Abstract][Full Text] [Related]
39. Molecular prognostic testing in uveal melanoma: has it finally come of age? Harbour JW Arch Ophthalmol; 2007 Aug; 125(8):1122-3. PubMed ID: 17698762 [No Abstract] [Full Text] [Related]
40. Preliminary results of the FRO project: chromosomal abnormalities in primary uveal melanoma. Cools D; Debiec-Rychter M; Parys-Van Ginderdeuren R; Hagemeijer-Hausman A; Van den Oord J; Spileers W Bull Soc Belge Ophtalmol; 2000; (278):67-70. PubMed ID: 11761564 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]